ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.590,89
-0,95%
S&P 500
5.631,22
0,28%
Dow Jones
40.211,72
0,53%
Euro vs US Dollar
1,08916
-0,07%
Bitcoin
64.263,91
-0,91%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Actelis Networks Inc (ASNS)

  7. Actelis Networks Inc (ASNS) News

ASNS

Actelis Networks (ASNS)

Actelis Networks Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ASNS
DatumZeitQuelleÜberschriftSymbolFirma
13/08/201814h20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ASNSActelis Networks Inc
13/08/201814h00GlobeNewswire Inc.Arsanis Reports Financial Results for Second Quarter 2018NASDAQ:ASNSActelis Networks Inc
10/08/201817h19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ASNSActelis Networks Inc
17/07/201822h30Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ASNSActelis Networks Inc
17/07/201822h28Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ASNSActelis Networks Inc
28/06/201813h12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ASNSActelis Networks Inc
28/06/201813h00GlobeNewswire Inc.Arsanis Provides Update Following Completion of Planned Interim Analysis of Phase 2 Clinical Trial of ASN100NASDAQ:ASNSActelis Networks Inc
14/06/201814h00GlobeNewswire Inc.Arsanis Out-Licenses Preclinical Stage Klebsiella pneumoniae Monoclonal Antibodies from ASN300 ProgramNASDAQ:ASNSActelis Networks Inc
12/06/201822h04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ASNSActelis Networks Inc
07/06/201823h12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ASNSActelis Networks Inc
07/06/201822h39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ASNSActelis Networks Inc
07/06/201822h26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ASNSActelis Networks Inc
07/06/201822h25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ASNSActelis Networks Inc
07/06/201822h24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ASNSActelis Networks Inc
07/06/201822h24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ASNSActelis Networks Inc
07/06/201822h23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ASNSActelis Networks Inc
07/06/201822h21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ASNSActelis Networks Inc
07/06/201822h19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ASNSActelis Networks Inc
10/05/201813h53Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ASNSActelis Networks Inc
10/05/201813h39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ASNSActelis Networks Inc
10/05/201813h00Business WireArsanis Reports Business Highlights and Financial Results for First Quarter 2018NASDAQ:ASNSActelis Networks Inc
23/04/201812h17Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ASNSActelis Networks Inc
20/04/201816h17PR Newswire (US)Antimicrobials Working Group Highlights Member Company Participation at the 28th European Congress of Clinical Microbiology a...NASDAQ:ASNSActelis Networks Inc
17/04/201814h00Business WireArsanis to Present at the 28th European Congress of Clinical Microbiology and Infectious DiseasesNASDAQ:ASNSActelis Networks Inc
04/04/201814h00Business WireArsanis Out-Licenses Preclinical Stage E. coli Monoclonal AntibodiesNASDAQ:ASNSActelis Networks Inc
20/03/201813h00Business WireArsanis to Present at the Needham & Company 17th Annual Healthcare ConferenceNASDAQ:ASNSActelis Networks Inc
14/03/201813h00Business WireArsanis Granted Key Patents for ASN100 Covering Cross-Neutralizing S. aureus Toxin AntibodiesNASDAQ:ASNSActelis Networks Inc
09/03/201822h43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ASNSActelis Networks Inc
09/03/201822h42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ASNSActelis Networks Inc
09/03/201822h39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ASNSActelis Networks Inc
 Showing the most relevant articles for your search:NASDAQ:ASNS

Kürzlich von Ihnen besucht

USOTC
BASFY
BASF (QX)
TG
TUI1
Tui
TG
CBK
Commerzbank
NYSE
MCD
McDonalds
NYSE
MRK
Merck
CCOM
US500
US 500
NYSE
DIS
Walt Disney
USOTC
ADDYY
Adidas (QX)
AMEX
XLF
Financial Select Sector
NASDAQ
AMZN
Amazon.com
NASDAQ
QQQ
Invesco QQQ Trust Series 1
COIN
BTCUSD
Bitcoin
CCOM
US100
US Tech 100
TG
D7G
Nel ASA
TG
BAS
BASF
DBI
MDAX
MDAX
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten